Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

Held, Stefanie Andrea Erika; Heine, Annkristin; Kesper, Anne Ruth; Schönberg, Kathrin; Beckers, Anika; Wolf, Dominik; Brossart, Peter.

Afiliação

Held SA; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn , Bonn, Germany.
Heine A; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn , Bonn, Germany.
Kesper AR; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn , Bonn, Germany.
Schönberg K; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn , Bonn, Germany.
Beckers A; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn , Bonn, Germany.
Wolf D; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn , Bonn, Germany.
Brossart P; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn , Bonn, Germany.

Oncoimmunology ; 5(1): e1065368, 2016.

Article em En | MEDLINE | ID: mdl-26942083